May 2022

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals

Co-Agent (ATM Offering)

Canaccord Genuity Acted as Co-Agent to Zynerba Pharmaceuticals on its $75 Million At-the-Market Offering

More Like This

July 2025

Deerfield Group

Financial Advisor to Deerfield Group on its Acquisition of Triple Threat Communications
July 2025

Greater Than One

Financial Advisor to Greater Than One on its Sale to Real Chemistry
US$175m

July 2025

Rhythm Pharmaceuticals

Lead Manager (Follow-On Offering)

View all Healthcare transactions